ANGINA PECTORIS
Clinical trials for ANGINA PECTORIS explained in plain language.
Never miss a new study
Get alerted when new ANGINA PECTORIS trials appear
Sign up with your email to follow new studies for ANGINA PECTORIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dissolvable magnesium stent could revolutionize heart disease treatment
Disease control Recruiting nowThis study tests a new device called Freesolve, a temporary magnesium scaffold that props open blocked heart arteries and then dissolves over time. About 1,859 people with up to two new blockages will receive either this scaffold or a standard permanent stent. The goal is to see …
Matched conditions: ANGINA PECTORIS
Phase: NA • Sponsor: Teleflex • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Tiny implant aims to relieve chest pain when Heart's small vessels fail
Disease control Recruiting nowThis early study tests a device called the A-FLUX Reducer, which is implanted into a vein in the heart to help blood flow. It is for people with chest pain caused by problems in the heart's tiny blood vessels (microvascular dysfunction). The study will enroll 30 adults and focus …
Matched conditions: ANGINA PECTORIS
Phase: NA • Sponsor: VahatiCor, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Dissolving stent could revolutionize treatment for long heart blockages
Disease control Recruiting nowThis study tests a new type of heart stent made from magnesium that slowly dissolves over time. It is designed for people with long blockages in their heart arteries. The goal is to see if the stent is safe and works well at keeping arteries open for up to 12 months. About 100 pa…
Matched conditions: ANGINA PECTORIS
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Dissolving stent could change heart disease treatment
Disease control Recruiting nowThis study compares a new type of heart stent called Freesolve, which is made of magnesium and dissolves over time, to a standard permanent metal stent. About 1,859 people with coronary artery disease will receive one of the two stents. The goal is to see if the dissolving stent …
Matched conditions: ANGINA PECTORIS
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
AI blood test could spot heart attacks faster
Diagnosis Recruiting nowThis study is testing whether artificial intelligence (AI) can predict or rule out a heart attack using data from standard blood tests. Researchers will analyze white blood cell properties from over 3,000 adults who come to the hospital with chest pain. The goal is to see if AI c…
Matched conditions: ANGINA PECTORIS
Sponsor: RobotDreams GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC